Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug
Teva divesting $1 billion in assets to clear Allergan deal
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
GSK's $235 million verdict revived against Teva, again | Reuters
Jury finds Teva fueled opioid addiction in New York - YouTube
Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Biden Admin Urges Supreme Court to Hear 'Skinny Labels' Case Between Teva, GSK
Teva enters billion-dollar settlement in US opioid case — MedWatch
Why Europe's Drug Shortages May Get Worse
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
What's 'down' with Teva? - Israel News - The Jerusalem Post
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters
Israel's Teva agrees to pay $126 mln to US hospitals over opioids
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Exclusive: Teva poised to raise its stake in Mylan - sources
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
